AU728405B2 - Substrate trapping protein tyrosine phosphatases - Google Patents

Substrate trapping protein tyrosine phosphatases Download PDF

Info

Publication number
AU728405B2
AU728405B2 AU59395/98A AU5939598A AU728405B2 AU 728405 B2 AU728405 B2 AU 728405B2 AU 59395/98 A AU59395/98 A AU 59395/98A AU 5939598 A AU5939598 A AU 5939598A AU 728405 B2 AU728405 B2 AU 728405B2
Authority
AU
Australia
Prior art keywords
protein
tyrosine phosphatase
val
leu
protein tyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59395/98A
Other languages
English (en)
Other versions
AU5939598A (en
Inventor
Andrew J. Flint
Nicholas Tonks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cold Spring Harbor Laboratory
Original Assignee
Cold Spring Harbor Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory filed Critical Cold Spring Harbor Laboratory
Publication of AU5939598A publication Critical patent/AU5939598A/en
Application granted granted Critical
Publication of AU728405B2 publication Critical patent/AU728405B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Alcoholic Beverages (AREA)
  • Peptides Or Proteins (AREA)
AU59395/98A 1996-07-25 1997-07-24 Substrate trapping protein tyrosine phosphatases Ceased AU728405B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/685992 1996-07-25
US08/685,992 US5912138A (en) 1996-07-25 1996-07-25 Substrate trapping protein tyrosine phosphatases
PCT/US1997/013016 WO1998004712A2 (en) 1996-07-25 1997-07-24 Substrate trapping protein tyrosine phosphatases

Publications (2)

Publication Number Publication Date
AU5939598A AU5939598A (en) 1999-02-16
AU728405B2 true AU728405B2 (en) 2001-01-11

Family

ID=24754471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59395/98A Ceased AU728405B2 (en) 1996-07-25 1997-07-24 Substrate trapping protein tyrosine phosphatases

Country Status (9)

Country Link
US (2) US5912138A (enExample)
EP (1) EP0918867B1 (enExample)
JP (1) JP2000515760A (enExample)
AT (1) ATE352625T1 (enExample)
AU (1) AU728405B2 (enExample)
CA (1) CA2262440A1 (enExample)
DE (1) DE69737290T2 (enExample)
ES (1) ES2281915T3 (enExample)
WO (1) WO1998004712A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
AU3922999A (en) * 1998-05-21 1999-12-13 Mcgill University Agents interfering with the binding of protein tyrosine phosphatase pest to domains of signalling proteins as inhibitors of cell migration and/or of focal adhesion
US6156551A (en) * 1998-06-05 2000-12-05 Beth Israel Deaconess Medical Center Activated mutants of SH2-domain-containing protein tyrosine phosphatases and methods of use thereof
US6248327B1 (en) 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US7176289B1 (en) 1998-09-11 2007-02-13 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US6355786B1 (en) 1998-10-30 2002-03-12 Vanderbilt University Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same
CA2366101A1 (en) * 1999-03-08 2000-09-14 Merck Frosst Canada & Co. Intact cell assay for protein tyrosine phosphatases
US6852520B1 (en) 1999-03-24 2005-02-08 Ceptyr, Inc. DSP-2 dual-specificity phosphatase
US6492157B1 (en) 1999-04-07 2002-12-10 Ceptyr, Inc. DSP-9 dual-specificity phosphatase
US6841369B1 (en) 1999-04-07 2005-01-11 Ceptyr, Inc. DSP-4 dual specificity phosphatase
US6551810B1 (en) 1999-04-23 2003-04-22 Ceptyr, Inc. DSP-10 dual-specificity phosphatase
US6645753B1 (en) 1999-04-27 2003-11-11 Ceptyr, Inc. DSP-5 dual-specificity phosphatase
CA2375145A1 (en) * 1999-06-03 2000-12-14 Cold Spring Harbor Laboratory Substrate trapping protein tyrosine phosphatases
US7078210B2 (en) 1999-07-02 2006-07-18 Ceptyr, Inc. DSP-3 dual-specificity phosphatase
EP1200602A1 (en) 1999-07-20 2002-05-02 Ceptyr, Inc. Dsp-11 dual-specificity map kinase phophatase
WO2001057221A2 (en) 2000-02-02 2001-08-09 Ceptyr, Inc. Dsp-12 and dsp-13 dual-specificity phosphatases
CA2435507A1 (en) * 2000-02-14 2001-08-23 Ceptyr, Inc. Improved assay for protein tyrosine phosphatases
US6825021B2 (en) 2000-09-19 2004-11-30 Ceptyr, Inc. DSP-15 dual-specificity phosphatase
US8071348B2 (en) * 2002-01-14 2011-12-06 Albert Einstein College Of Medicine Of Yeshiva University Protein tyrosine phosphatase substrate-trapping double mutant and uses thereof
US20030215899A1 (en) * 2002-02-13 2003-11-20 Ceptyr, Inc. Reversible oxidation of protein tyrosine phosphatases
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
WO2003099227A2 (en) * 2002-05-23 2003-12-04 Ceptyr, Inc. Modulation of ptp1b signal transduction by rna interference
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
EP1576139A4 (en) * 2002-11-26 2007-06-20 Cold Spring Harbor Lab INTERACTIVE PROTEINS AND ASSOCIATED METHODS OF DEP-1 RECEPTOR PROTEIN-TYROSINE PHOSPHATASE
US20070238129A1 (en) * 2006-03-29 2007-10-11 Moyer Susanne C Catalytically inactive enzymes for affinity binding
WO2011060076A1 (en) * 2009-11-10 2011-05-19 Amgen Inc. Anti-c-mpl antibodies
CN113899902B (zh) * 2020-06-22 2024-10-29 上海科技大学 一种酪氨酸磷酸酶底物鉴定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054602C (en) * 1991-10-31 2003-04-22 Anthony Pawson Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system
US5589375A (en) * 1992-10-06 1996-12-31 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. PTP 1D: a novel protein tyrosine phosphatase
US5585233A (en) * 1993-03-23 1996-12-17 Max-Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. PTP-S31: A novel protein tyrosine phosphatase
WO1995006735A2 (en) * 1993-09-01 1995-03-09 The Ludwig Institute For Cancer Research Nucleotide sequences for novel protein tyrosine phosphatases
US5744313A (en) * 1994-12-09 1998-04-28 The Regents Of The University Of California Assay employing novel protein domain which binds tyrosine phosphorylated proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PROTEIN SCIENCE, 5, 1996, ECKSTEIN ET AL., 5-12 *

Also Published As

Publication number Publication date
US5951979A (en) 1999-09-14
ES2281915T3 (es) 2007-10-01
US5912138A (en) 1999-06-15
WO1998004712A2 (en) 1998-02-05
EP0918867B1 (en) 2007-01-24
EP0918867A2 (en) 1999-06-02
WO1998004712A3 (en) 1998-03-12
JP2000515760A (ja) 2000-11-28
DE69737290T2 (de) 2007-11-08
AU5939598A (en) 1999-02-16
ATE352625T1 (de) 2007-02-15
DE69737290D1 (en) 2007-03-15
CA2262440A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
AU728405B2 (en) Substrate trapping protein tyrosine phosphatases
Garton et al. Identification of p130 cas as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST
Garton et al. Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition
US6579972B1 (en) Extracellular signal-regulated kinase, sequences, and methods of production and use
WO1995024205A1 (en) Methods and compositions for treatment of breast cancer
CZ296185B6 (cs) Varianty proteinu p53 a jejich terapeutické pouzití
US6800483B1 (en) Compositions and methods for sensitizing and inhibiting growth of human tumor cells
WO2000075339A1 (en) Substrate trapping protein tyrosine phosphatases
US9068174B2 (en) Method for sensitizing tumor cells to chemotherapeutic prodrug CPT-11
US6849438B1 (en) Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1)
Ghosh et al. cDNA encoding a functional feline liver/bone/kidney-type alkaline phosphatase
CA2385266C (en) Novel cell cycle checkpoint genes and proteins encoded thereby
US9492510B2 (en) Composition and method for inhibiting tumor cell growth
WO1996000586A9 (en) Methods for treating cell proliferative disorders by modulating signal transduction
CA2362936A1 (en) A caspase activated protein kinase

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)